- Home
- ATNM vs RGT Comparison
ATNM vs RGT Comparison
Compare ATNM & RGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- RGT
- Stock Information
- Founded
- ATNM 2000
- RGT 1986
- Country
- ATNM United States
- RGT United States
- Employees
- ATNM N/A
- RGT N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- RGT Trusts Except Educational Religious and Charitable
- Sector
- ATNM Health Care
- RGT Finance
- Exchange
- ATNM Nasdaq
- RGT Nasdaq
- Market Cap
- ATNM 56.5M
- RGT 67.6M
- IPO Year
- ATNM N/A
- RGT N/A
- Fundamental
- Price
- ATNM $1.40
- RGT $11.00
- Analyst Decision
- ATNM Strong Buy
- RGT
- Analyst Count
- ATNM 4
- RGT 0
- Target Price
- ATNM $8.75
- RGT N/A
- AVG Volume (30 Days)
- ATNM 342.1K
- RGT 22.4K
- Earning Date
- ATNM 11-14-2024
- RGT 01-01-0001
- Dividend Yield
- ATNM N/A
- RGT 1.43%
- EPS Growth
- ATNM N/A
- RGT N/A
- EPS
- ATNM N/A
- RGT 0.92
- Revenue
- ATNM $81,000.00
- RGT N/A
- Revenue This Year
- ATNM $138.42
- RGT N/A
- Revenue Next Year
- ATNM $19,479.88
- RGT N/A
- P/E Ratio
- ATNM N/A
- RGT $11.42
- Revenue Growth
- ATNM N/A
- RGT N/A
- 52 Week Low
- ATNM $1.10
- RGT $7.84
- 52 Week High
- ATNM $10.24
- RGT $11.08
- Technical
- Relative Strength Index (RSI)
- ATNM 56.03
- RGT 50.38
- Support Level
- ATNM $1.18
- RGT $10.79
- Resistance Level
- ATNM $1.48
- RGT $11.00
- Average True Range (ATR)
- ATNM 0.10
- RGT 0.17
- MACD
- ATNM 0.01
- RGT 0.05
- Stochastic Oscillator
- ATNM 75.00
- RGT 77.42
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.